Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 122 of 5804
-
Massive norwegian study aims to slash colon cancer deaths with simple screening
Prevention OngoingThe purpose of this study is to see if screening with flexible sigmoidoscopy (a flexible viewing tube) may reduce large bowel cancer and cancer deaths. The researchers also want to see if the addition of screening for occult blood in stools may contribute further to this aim. Add…
Phase: NA • Sponsor: Norwegian Institute of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Lifesaving drug now available for kids with rare gut disease
Disease control APPROVED_FOR_MARKETINGThe program is to provide access to an experimental drug called pozelimab and to document the long-term safety of pozelimab in patients with Protein-Losing Enteropathy (PLE). CD55-deficient PLE/CHAPLE disease is a rare inherited disease of the immune system. This can be a life-th…
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for kids with rare copper deficiency disease
Disease control APPROVED_FOR_MARKETINGThis expanded access protocol provides subcutaneous copper histidinate for Menkes disease patients under 6 years of age.
Sponsor: Sentynl Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Breakthrough Stent-Graft approved for deadly aortic aneurysms
Disease control APPROVED_FOR_MARKETINGExpanded access tothe GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis is safe and effective in the treatment of thoracoabdominal and pararenal aneurysms.
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental drug offers hope for babies with rare genetic brain condition
Disease control AVAILABLEMonocarboxylate Transporter 8 (MCT8) deficiency (that is also known as Allan-Herndon-Dudley syndrome) is a rare X-linked inherited disorder of brain development that causes severe intellectual disability and problems with movement. This condition, which occurs almost exclusively …
Sponsor: Roy E. Weiss, M.D. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Gene therapy offers hope for sickle cell patients by boosting healthy hemoglobin
Disease control TEMPORARILY_NOT_AVAILABLEA promising approach for the treatment of genetic diseases is called gene therapy. Gene therapy is a relatively new field of medicine in which genetic material (mostly DNA) in the patient is changed to treat his or her own disease. In gene therapy, we introduce new genetic materi…
Sponsor: David Williams • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a One-Time surgical product help regrow severed nerves?
Disease control AVAILABLEThe proposed use of NTX-001 for transections of upper extremity and facial peripheral nerves, acutely or planned.
Sponsor: Neuraptive Therapeutics Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New heart pump could offer lifeline for advanced heart failure patients
Disease control Not yet recruitingTo evaluate the safety and effectiveness of the Corheart 6 left ventricular assist system in providing mechanical support for blood circulation in patients with advanced left ventricular heart failure.
Phase: NA • Sponsor: Shenzhen Core Medical Technology CO.,LTD. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Drug combo aims to shrink NF2 tumors and save hearing
Disease control Not yet recruitingThis is an investigator-initiated, exploratory, multicenter, open-label, single-arm clinical trial and a substudy of the Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2). The study aims to evaluate the safety, tolerability, and preliminary efficacy of luvometinib…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Weekly shot could help shed pounds in obesity trial
Disease control Not yet recruitingThis randomized, double-blind, parallel, placebo-controlled phase Ⅲ study to evaluate the efficacy and safety of UBT251 Injection in overweight/obese patients
Phase: PHASE3 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can targeted electrical pulses quiet an erratic heartbeat?
Disease control Not yet recruitingThis clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of …
Phase: NA • Sponsor: Shanghai MicroPort EP MedTech Co., Ltd. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Heart rate drug may speed recovery from shock after heart attack
Disease control Recruiting nowBrief Summary: The IVASHOCK trial investigates whether ivabradine can achieve at least one-class improvement in SCAI cardiogenic shock classification compared to placebo, and evaluates its safety profile in patients with cardiogenic shock (CS). Primary Objectives: 1. To determ…
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
AI 'PANDAPro' hunts hidden pancreatic cancers in 100,000 CT scans
Diagnosis OngoingThe purpose of this study is to build upon the previously developed deep learning-based non-contrast CT pancreatic cancer screening model, PANDA. The model will first undergo training and enhancement, followed by external validation across multiple centers. Subsequently, a large-…
Phase: NA • Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
New Light-Based device could spot brain bleeds in minutes without a CT scan
Diagnosis Not yet recruitingTraumatic Brain Injury (TBI) is a leading cause of death and disability among military personnel, Veterans, and civilians. One of the most dangerous complications of moderate-to-severe TBI is intracranial hemorrhage (ICH). If not identified and treated promptly, ICH can rapidly l…
Sponsor: The Geneva Foundation • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Spinal implant aims to restore walking in paralyzed patients
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and effectiveness of Epidural Electrical Stimulation (EES) combined with rehabilitation training for the reconstruction of walking in patients with chronic spinal cord injury (SCI) classified as AIS B-D. The main questions…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can fewer Pre-Surgery doses of immunotherapy beat more in head and neck cancer?
Disease control Recruiting nowThis study aims to explore the optimal course of neoadjuvant immunotherapy for HNSCC by comparing the efficacy and safety of 4 cycles and 2 cycles of neoadjuvant tislelizumab combined with chemotherapy.
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for Crohn's: duvakitug enters final testing phase
Disease control Recruiting nowThis is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active CD. Study details include: The study durat…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Foam that stops bleeding from the inside: new trial underway
Disease control Recruiting nowThe purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.
Phase: NA • Sponsor: Arsenal Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a Mother's diet during pregnancy prevent peanut and egg allergies in her baby?
Prevention Recruiting nowPeanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on matern…
Phase: NA • Sponsor: University of Rochester • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Diaper photos may spot hidden liver disease in babies
Diagnosis Recruiting nowThis observational study evaluates whether a machine-learning algorithm, a computer program that learns patterns from data, can accurately diagnose cholestasis in newborns. Cholestasis refers to reduced or blocked bile flow from the liver, which can lead to liver damage. A severe…
Sponsor: Birmingham Women's and Children's NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC